Cardiac Pacemaker Development

心脏起搏器开发

基本信息

  • 批准号:
    8237943
  • 负责人:
  • 金额:
    $ 38.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-02 至 2016-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cardiac pacemaker cells of the Sinoatrial Node are essential for producing rhythmic heartbeats. Despite the importance of this specialized cardiac cell type, little is known about their ontogeny or mechanisms of specification and differentiation. Our preliminary data show that although the primary heart tube initially displays rhythmic beating, the cells pacing it do not differentiate into the Sinoatrial Node. Instead, pacemaker precursors arise from the mesoderm posterior to the known cardiogenic field and take over the pacing function during heart-looping. Surprisingly, the pacemaker precursor mesoderm can differentiate in culture without any other surrounding embryonic tissues. They display sustained rhythmic beat rates, and sensitivity to pacemaker cell specific ion channel blockers. Furthermore, they have the ability to pace other cardiomyocyte populations. Our global RNA profiling has identified a unique set of Wnt-related genes expressed in pacemaker precursors. These somewhat surprising findings lead to three central hypotheses: (1) the pacemaker precursors arise from a specific mesoderm population separate from the heart field; (2) pacemaker cell fate is induced prior to heart tube formation; and (3) Wnt-related signaling, which is inhibitory to the heart field, acts as a promoting signal during pacemaker cell specification. We will test these hypotheses experimentally. This proposal will provide the first basis for identifying the embryonic origin of pacemaker precursors (Aim 1), the ability of a specific mesoderm subpopulations to enter the pacemaker cell fate (Aim 2), and novel molecular mechanisms that specify and direct the differentiation this important cell type during a brief temporal window and at a defined site in the embryo (Aim 3). PUBLIC HEALTH RELEVANCE: The cardiac pacemaker is essential for cardiac function and survival. Limited options of effective treatments contribute to the continued prevalence of arrhythmic heart disease. The proposed study will explore the molecular mechanisms that regulate the earliest developmental steps leading to the generation of this essential cardiac tissue and may provide a basis for future therapeutic approaches.
描述(由申请人提供):窦房结的心脏起搏细胞对于产生节律性心跳至关重要。尽管这种特殊的心脏细胞类型的重要性,很少有人知道他们的个体发育或规范和分化的机制。我们的初步数据显示,虽然主心管最初显示有节奏的跳动,起搏它的细胞不分化成窦房结。相反,起搏器前体产生于已知心源性场后面的中胚层,并在心脏循环期间接管起搏功能。令人惊讶的是,起搏器前体中胚层可以在没有任何其他周围胚胎组织的培养中分化。它们表现出持续的节律性搏动率,以及对起搏细胞特异性离子通道阻滞剂的敏感性。此外,它们还具有调节其他心肌细胞群的能力。我们的全球RNA分析已经确定了一组独特的Wnt相关基因在起搏器前体中表达。这些有些令人惊讶的发现导致了三个中心假设:(1)起搏器前体来自与心脏领域分开的特定中胚层群体;(2)起搏器细胞命运在心管形成之前被诱导;和(3)Wnt相关信号传导,其对心脏领域具有抑制作用,在起搏器细胞特化期间充当促进信号。我们将用实验来检验这些假设。这一提议将为鉴定起搏器前体的胚胎起源(目标1)、特定中胚层亚群进入起搏器细胞命运的能力(目标2)以及在短暂的时间窗期间和胚胎中的确定位点指定和指导这种重要细胞类型分化的新分子机制(目标3)提供第一个基础。 公共卫生相关性:心脏起搏器对心脏功能和生存至关重要。有效治疗方法的选择有限,导致了冠心病的持续流行。这项拟议的研究将探索调节导致这种重要心脏组织产生的最早发育步骤的分子机制,并可能为未来的治疗方法提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Takashi Mikawa其他文献

Takashi Mikawa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Takashi Mikawa', 18)}}的其他基金

Induction and Patterning of Cardiogenic Fields
心源场的感应和模式化
  • 批准号:
    10668338
  • 财政年份:
    2020
  • 资助金额:
    $ 38.63万
  • 项目类别:
Induction and Patterning of Cardiogenic Fields
心源场的感应和模式化
  • 批准号:
    10033231
  • 财政年份:
    2020
  • 资助金额:
    $ 38.63万
  • 项目类别:
Induction and Patterning of Cardiogenic Fields
心源场的感应和模式化
  • 批准号:
    10249281
  • 财政年份:
    2020
  • 资助金额:
    $ 38.63万
  • 项目类别:
Induction and Patterning of Cardiogenic Fields
心源场的感应和模式化
  • 批准号:
    10459497
  • 财政年份:
    2020
  • 资助金额:
    $ 38.63万
  • 项目类别:
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
  • 批准号:
    10198034
  • 财政年份:
    2019
  • 资助金额:
    $ 38.63万
  • 项目类别:
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
  • 批准号:
    10447576
  • 财政年份:
    2019
  • 资助金额:
    $ 38.63万
  • 项目类别:
Atrioventricular Junction Development
房室交界区发育
  • 批准号:
    9750008
  • 财政年份:
    2016
  • 资助金额:
    $ 38.63万
  • 项目类别:
Heart Field Development
心田开发
  • 批准号:
    8670630
  • 财政年份:
    2014
  • 资助金额:
    $ 38.63万
  • 项目类别:
Heart Field Development
心田开发
  • 批准号:
    9045697
  • 财政年份:
    2014
  • 资助金额:
    $ 38.63万
  • 项目类别:
Cardiac Pacemaker Development
心脏起搏器开发
  • 批准号:
    8585876
  • 财政年份:
    2011
  • 资助金额:
    $ 38.63万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
    WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 38.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了